Thomas A. Satterfield, Jr. 13D and 13G filings for Angion Biomedica Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-10 4:53 pm Purchase | 2022-12-31 | 13G | Angion Biomedica Corp. ANGN | Thomas A. Satterfield, Jr. | 221,338 7.350% | 63,884 (+40.57%) | Filing |
| 2022-05-19 10:04 am Purchase | 2022-05-17 | 13G | Angion Biomedica Corp. ANGN | Thomas A. Satterfield, Jr. | 157,455 5.300% | 157,455 (New Position) | Filing |